메뉴 건너뛰기




Volumn 195, Issue 11, 2015, Pages 5117-5122

Landscape of tumor antigens in T cell immunotherapy

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CARBONATE DEHYDRATASE IX; CHIMERIC ANTIGEN RECEPTOR; HLA ANTIGEN; IPILIMUMAB; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3; NY ESO 1 ANTIGEN; PEMBROLIZUMAB; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; DIFFERENTIATION ANTIGEN; EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR;

EID: 84948798960     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501657     Document Type: Review
Times cited : (132)

References (47)
  • 3
    • 0023093741 scopus 로고
    • Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma
    • Muul, L. M., P. J. Spiess, E. P. Director, and S. A. Rosenberg. 1987. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol. 138: 989-995.
    • (1987) J. Immunol. , vol.138 , pp. 989-995
    • Muul, L.M.1    Spiess, P.J.2    Director, E.P.3    Rosenberg, S.A.4
  • 4
    • 0344039007 scopus 로고
    • Cytolytic T-cell clones against an autologous human melanoma: Specificity study and definition of three antigens by immunoselection
    • Knuth, A., T. Wölfel, E. Klehmann, T. Boon, and K. H. Meyer zum Buschenfelde. 1989. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc. Natl. Acad. Sci. USA 86: 2804-2808.
    • (1989) Proc. Natl. Acad. Sci. USA , vol.86 , pp. 2804-2808
    • Knuth, A.1    Wölfel, T.2    Klehmann, E.3    Boon, T.4    Meyer Zum Buschenfelde, K.H.5
  • 17
    • 84928912377 scopus 로고    scopus 로고
    • A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: Long-term follow-up and correlates with response
    • Robbins, P. F., S. H. Kassim, T. L. Tran, J. S. Crystal, R. A. Morgan, S. A. Feldman, J. C. Yang, M. E. Dudley, J. R. Wunderlich, R. M. Sherry, et al. 2015. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response. Clin. Cancer Res. 21: 1019-1027. doi:10. 1158/1078-0432. CCR-14-2708.
    • (2015) Clin. Cancer Res. , vol.21 , pp. 1019-1027
    • Robbins, P.F.1    Kassim, S.H.2    Tran, T.L.3    Crystal, J.S.4    Morgan, R.A.5    Feldman, S.A.6    Yang, J.C.7    Dudley, M.E.8    Wunderlich, J.R.9    Sherry, R.M.10
  • 18
    • 71049153709 scopus 로고    scopus 로고
    • Cancer/testis (CT) antigens: Potential targets for immunotherapy
    • Caballero, O. L., and Y. T. Chen. 2009. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100: 2014-2021.
    • (2009) Cancer Sci. , vol.100 , pp. 2014-2021
    • Caballero, O.L.1    Chen, Y.T.2
  • 20
    • 84863337890 scopus 로고    scopus 로고
    • B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
    • Kochenderfer, J. N., M. E. Dudley, S. A. Feldman, W. H. Wilson, D. E. Spaner, I. Maric, M. Stetler-Stevenson, G. Q. Phan, M. S. Hughes, R. M. Sherry, et al. 2012. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 119: 2709-2720.
    • (2012) Blood , vol.119 , pp. 2709-2720
    • Kochenderfer, J.N.1    Dudley, M.E.2    Feldman, S.A.3    Wilson, W.H.4    Spaner, D.E.5    Maric, I.6    Stetler-Stevenson, M.7    Phan, G.Q.8    Hughes, M.S.9    Sherry, R.M.10
  • 22
    • 84933510694 scopus 로고    scopus 로고
    • CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
    • Maude, S. L., D. T. Teachey, D. L. Porter, and S. A. Grupp. 2015. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood 125: 4017-4023.
    • (2015) Blood , vol.125 , pp. 4017-4023
    • Maude, S.L.1    Teachey, D.T.2    Porter, D.L.3    Grupp, S.A.4
  • 23
    • 33646440024 scopus 로고    scopus 로고
    • Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: First clinical experience
    • Lamers, C. H., S. Sleijfer, A. G. Vulto, W. H. Kruit, M. Kliffen, R. Debets, J. W. Gratama, G. Stoter, and E. Oosterwijk. 2006. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. J. Clin. Oncol. 24: e20-e22.
    • (2006) J. Clin. Oncol. , vol.24 , pp. e20-e22
    • Lamers, C.H.1    Sleijfer, S.2    Vulto, A.G.3    Kruit, W.H.4    Kliffen, M.5    Debets, R.6    Gratama, J.W.7    Stoter, G.8    Oosterwijk, E.9
  • 25
    • 77950475517 scopus 로고    scopus 로고
    • Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2
    • Morgan, R. A., J. C. Yang, M. Kitano, M. E. Dudley, C. M. Laurencot, and S. A. Rosenberg. 2010. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol. Ther. 18: 843-851.
    • (2010) Mol. Ther. , vol.18 , pp. 843-851
    • Morgan, R.A.1    Yang, J.C.2    Kitano, M.3    Dudley, M.E.4    Laurencot, C.M.5    Rosenberg, S.A.6
  • 26
    • 0029125899 scopus 로고
    • A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma
    • Coulie, P. G., F. Lehmann, B. Lethé, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA 92: 7976-7980.
    • (1995) Proc. Natl. Acad. Sci. USA , vol.92 , pp. 7976-7980
    • Coulie, P.G.1    Lehmann, F.2    Lethé, B.3    Herman, J.4    Lurquin, C.5    Andrawiss, M.6    Boon, T.7
  • 28
    • 0029669950 scopus 로고    scopus 로고
    • A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
    • Robbins, P. F., M. El-Gamil, Y. F. Li, Y. Kawakami, D. Loftus, E. Appella, and S. A. Rosenberg. 1996. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183: 1185-1192.
    • (1996) J. Exp. Med. , vol.183 , pp. 1185-1192
    • Robbins, P.F.1    El-Gamil, M.2    Li, Y.F.3    Kawakami, Y.4    Loftus, D.5    Appella, E.6    Rosenberg, S.A.7
  • 31
    • 84880276438 scopus 로고    scopus 로고
    • Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
    • Robbins, P. F., Y. C. Lu, M. El-Gamil, Y. F. Li, C. Gross, J. Gartner, J. C. Lin, J. K. Teer, P. Cliften, E. Tycksen, et al. 2013. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat. Med. 19: 747-752.
    • (2013) Nat. Med. , vol.19 , pp. 747-752
    • Robbins, P.F.1    Lu, Y.C.2    El-Gamil, M.3    Li, Y.F.4    Gross, C.5    Gartner, J.6    Lin, J.C.7    Teer, J.K.8    Cliften, P.9    Tycksen, E.10
  • 42
    • 48249117436 scopus 로고    scopus 로고
    • High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: A retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006
    • Klapper, J. A., S. G. Downey, F. O. Smith, J. C. Yang, M. S. Hughes, U. S. Kammula, R. M. Sherry, R. E. Royal, S. M. Steinberg, and S. Rosenberg. 2008. High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer 113: 293-301.
    • (2008) Cancer , vol.113 , pp. 293-301
    • Klapper, J.A.1    Downey, S.G.2    Smith, F.O.3    Yang, J.C.4    Hughes, M.S.5    Kammula, U.S.6    Sherry, R.M.7    Royal, R.E.8    Steinberg, S.M.9    Rosenberg, S.10
  • 46
    • 84903846565 scopus 로고    scopus 로고
    • Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions
    • Lu, Y. C., X. Yao, J. S. Crystal, Y. F. Li, M. El-Gamil, C. Gross, L. Davis, M. E. Dudley, J. C. Yang, Y. Samuels, et al. 2014. Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions. Clin. Cancer Res. 20: 3401-3410. doi:10. 1158/1078-0432. CCR-14-0433.
    • (2014) Clin. Cancer Res. , vol.20 , pp. 3401-3410
    • Lu, Y.C.1    Yao, X.2    Crystal, J.S.3    Li, Y.F.4    El-Gamil, M.5    Gross, C.6    Davis, L.7    Dudley, M.E.8    Yang, J.C.9    Samuels, Y.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.